<DOC>
	<DOCNO>NCT00944307</DOCNO>
	<brief_summary>The purpose study test whether drug interaction raltegravir ( medicine use treat human immunodeficiency virus HIV ) antacid .</brief_summary>
	<brief_title>Effect Antacids Pharmacokinetics Raltegravir</brief_title>
	<detailed_description>This study determine interaction occur HIV medicine raltegravir antacid . A prior study find interaction another medicine like raltegravir call elvitegravir antacid . The elvitegravir level reduce half . The interaction may occur raltegravir antacid base structure medicine work . When level HIV medication reduce , people HIV `` fail '' treatment . The virus multiply drug level low medication stop work . We need sure antacid cause problem raltegravir .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , simethicone drug combination</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>TEMPO</mesh_term>
	<criteria>Absence HIV1 infection document licensed ELISA test kit within 21 day prior study entry . Age great equal 18 less equal 60 year . Ability willingness give write informed consent . Within 30 % ( +/ ) ideal body weight total body weight â‰¥ 50 kg . Hematology , Metabolic Profile , Renal , Hepatic Function test within normal limit . Creatine kinase ( CK ) less 3 time upper limit normal Pregnancy breastfeeding . Women men reproductive potential actively engage sexual activity assist reproductive technology intent pregnancy . Allergy/sensitivity raltegravir . Allergy/sensitivity antacid . Active drug alcohol abuse dependence , opinion investigator , would interfere adherence study requirement . While study , subject instruct consume alcohol 48 hour prior screen visit , 24 hour precede intensive pharmacokinetic ( PK ) study visit 24 hour follow completion study visit . Any medical condition , opinion investigator , would interfere subject 's ability participate protocol . Participation investigational drug study within 30 day prior study entry . History active cardiovascular , renal , hematologic , hepatic , neurologic , gastrointestinal , psychiatric , endocrine , immunologic disease ( ) . This inclusive chronic illness hypertension , coronary artery disease , arthritis , diabetes , chronic gastrointestinal condition might interfere drug absorption . Use investigational , prescription , overthecounter medication within 14 day study entry follow exception : aspirin , acetaminophen , ibuprofen , oral contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>antiretroviral</keyword>
	<keyword>drug interaction</keyword>
	<keyword>human immunodeficiency virus</keyword>
</DOC>